Elon Musk's Tesla faces fresh criticism from ‘Big Short' investor Michael Burry

Michael Burry labeled Tesla "ridiculously overvalued," calculating that ongoing share issuance without buybacks dilutes existing shareholders by roughly 3.6% annually and warning Musk’s revised compensation package will add further dilution. Tesla shareholders approved a plan potentially granting Musk up to about 12% of stock (worth up to ~$1 trillion if market cap reaches $8.5 trillion); Tesla’s market value was about $1.43 trillion in late November 2025 and Musk holds roughly 13% of shares. The revised pay plan follows a 2024 Delaware ruling voiding an earlier $56 billion package, and shares were trading around $427–$430 at the time of reporting.

Analysis

Market structure: Burry’s call highlights direct winners (short sellers, value auto peers such as TM/BYD) and losers (index-heavy TSLA holders and retail momentum players). The explicit 3.6% annual dilution claim and Musk’s potential 12% award create a recurring supply overhang versus demand that justifies a higher cost of capital and compresses TSLA pricing power vs. traditional OEMs (Tesla $1.43T vs. Toyota ~$260B). NVDA/PLTR sentiment may wobble from cross-tech skepticism but remain driven by fundamental AI adoption cycles.

Risk assessment: Immediate (days) — volatility spike and flows into TSLA options; short-term (weeks/months) — potential re-rating if dilution narrative gains traction or if Musk/Tesla insider selling increases; long-term (quarters/years) — cumulative dilution (>3.6% p.a.) materially reduces per-share economic claim unless offset by >10–15% annual FCF growth. Tail risks include adverse Delaware rulings, securities litigation, or a forced equity issuance topping 5–10% in a stress event.

Trade implications: Favor asymmetric, limited-loss shorts on TSLA: use 3–6 month put spreads (size 1–2% portfolio) to express a 15–30% downside view while buying value auto exposure (TM 2–3% notional) as a relative-value hedge. Avoid naked shorting; consider buying TSLA-to-TM pair puts (short TSLA/long TM) or selling short-dated TSLA call spreads into rallies. Keep NVDA exposures long-term but trim 5–10% on pop; consider buying protective put hedges for large AI longs.

Contrarian angles: Consensus underestimates that dilution is mechanical but partially offset if Tesla converts FSD/robotaxi into high-margin recurring revenue — this would require >$20–30B incremental revenue within 3–5 years to justify current cap. Reaction may be overdone short-term (expect mean reversion on delivery beats), but structural mispricing persists if dilution continues and no buybacks occur; activist pressure or a binding lockup on Musk could flip the trade quickly.

Key Decisions for Investors

• Establish a 1.5–2.0% portfolio-sized short exposure to TSLA via 3–6 month put spreads (example: buy 6-month 350/300 put spread or equivalent delta structure) to cap downside and target a 15–30% drop in shares within 3–6 months.
• Initiate a 2–3% long position in Toyota (TM) or another cash-flow positive OEM as a relative-value hedge (pair trade: long TM notional vs. short TSLA notional 1:1), aiming to capture valuation convergence from current ~5x market-cap gap.
• Trim existing NVDA exposure by 5–10% on any >5% intraday pop and deploy proceeds to fund TSLA hedges; alternatively buy 2–3% portfolio protective puts on NVDA with 3-month expiry if downside volatility rises >25% implied.
• If a Delaware court decision or SEC action reversing/limiting Musk’s compensation occurs within 90 days, scale short TSLA by additional 1–2% notional; conversely, if Tesla announces a material buyback or FCF beat (>20% beat to consensus) within 60 days, close shorts and reassess.